Vinge advises Aneo on its public offer for Scandinavian Biogas

Aneo Renewables Holding AS has made a public mandatory bid for all shares in Scandinavian Biogas Fuels International AB. The offer values the shares of Scandinavian Biogas at approximately SEK 670 million. Vinge advises Aneo.

Vinge advised Aneo in connection with the directed share issue by Scandinavian Biogas

Scandinavian Biogas Fuels International AB has carried out a directed share issue of SEK 326 million. Vinge advised Aneo Renewables Holding AS (Scandinavian Biogas’ largest shareholder).

Vinge has advised Re:NewCell in connection with a directed share issue

Vinge has advised Re:NewCell, a textile-to-textile recycling company listed on Nasdaq First North Premier Growth Market, in connection with a directed share issue whereby the company raised proceeds of approximately SEK 158 million before issue costs.

Vinge has advised Azelio in connection with its rights issue

Vinge has advised Azelio AB (publ) on a fully guaranteed rights issue, which will provide Azelio with issue proceeds amounting to approximately SEK 300 million before deduction of transaction costs.

Vinge has advised Xspray Pharma in connection with share issue

Vinge has advised Xspray Pharma, a pharmaceutical company with several product candidates in clinical development listed on Nasdaq Stockholm, in connection with a share issue whereby the company raises proceeds of SEK 100 million.

Vinge advises Semcon in connection with the offer by Ratos

Vinge is advising Semcon AB (publ) due to the fact that Ratos AB has provided a competing recommended cash offer to the shareholders of Semcon.

Vinge advised Nordea in connection with Karo Intressenter’s public offer for Karo Pharma

Vinge has advised Nordea Bank Abp, filial i Sverige, Corporate Finance in connection with the rendering of a fairness opinion regarding Karo Intressenter’s public offer to the shareholders of Karo Pharma AB.

Vinge advises Vimian in connection with a directed share issue of approximately MSEK 1,500

Vinge advises Vimian in connection with a directed share issue of approximately MSEK 1,500, before issue costs.

Vinge advises Xintela

Vinge has advised Xintela in connection with the mandatory public offer from Flerie Invest AB.

Vinge advises Semcon in connection with the offer from Etteplan

Vinge has advised Semcon AB (publ) in connection with a public takeover offer provided by Etteplan Oyj to the shareholders of Semcon. The offer prices SEK 149 per share and values Semcon AB approximately SEK 2 699.

Vinge advises the founders of Future Media Group in conjunction with the sale to Caybon

Vinge has advised the founders Rikard Virta, Linus Wennerström and Johan Oscarsson as well as the other shareholders in conjunction with the sale of Future Media Group AB to Caybon.

Vinge advises Oncopeptides in connection with a directed share issue

The board of directors of Oncopeptides has resolved on a directed new issue of shares, whereby Oncopeptides will raise proceeds of approximately SEK 435,6 million, before issue costs. The price per share in the share issue corresponds to the closing price on Nasdaq Stockholm the day of the share issue.

Vinge has advised Studentbostäder i Norden AB (publ) in connection with a directed share issue

Vinge has advised Studentbostäder i Norden in connection with a directed share issue whereby the company receives SEK 125 million in issue proceeds before deduction of transaction costs.

Vinge advises Lagercrantz Group in conjunction with acquisition of PcP Corporation

Vinge has advised Lagercrantz Group in conjunction with acquisition of 95 % of the shares in the Danish business group PcP Corporation A/S, a leading product company with innovative, high quality, customer adapted security solutions. The acquisition was performed for a total enterprise value of approximately SEK 500 million.

Vinge advises Cantargia in connection with rights issue

Vinge advises Cantargia AB (publ) in connection with a fully covered rights issue of approximately SEK 250 million.